Literature DB >> 21179474

Mathematical modeling for the pathogenesis of Alzheimer's disease.

Ishwar K Puri1, Liwu Li.   

Abstract

Despite extensive research, the pathogenesis of neurodegenerative Alzheimer's disease (AD) still eludes our comprehension. This is largely due to complex and dynamic cross-talks that occur among multiple cell types throughout the aging process. We present a mathematical model that helps define critical components of AD pathogenesis based on differential rate equations that represent the known cross-talks involving microglia, astroglia, neurons, and amyloid-β (Aβ). We demonstrate that the inflammatory activation of microglia serves as a key node for progressive neurodegeneration. Our analysis reveals that targeting microglia may hold potential promise in the prevention and treatment of AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21179474      PMCID: PMC3001872          DOI: 10.1371/journal.pone.0015176

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Alzheimer's disease (AD) is one of the most prevalent neurodegenerative disorders associated with aging, causing dementia and related severe public health concerns [1]. Despite extensive research effort and progress, the pathogenesis of AD remains incompletely understood, partly due to highly complex and intertwined intercellular cross-talks taking place throughout the aging process [2]. Consequently, despite limited treatment options to manage and slow the progression of AD, no effective cure is available. Although the deposition of amyloid-β (Aβ) peptides and formation of senile plaques in the brain is the cardinal morphological feature identifying the clinical phenotype of AD [3], [4], increasing clinical and basic studies suggest that inflammatory activation of microglia may play an equally important role during the initiation and progression of the disease [5]. Microglia are resident innate immune macrophages within brain tissues, capable of expressing pro-inflammatory mediators and reactive oxygen species when activated by inflammatory signals including amyloid-β (Aβ) [6]. In healthy brains, together with quiescent astroglia (Aq), resting microglia may adopt an anti-inflammatory state (M2) and in turn foster neuron survival (Ns) and prevent astroglia proliferation (Ap) [7], [8]. As inflammatory signals (e.g. Aβ) gradually build, microglia may adopt an activated pro-inflammatory state (M1), leading to Ap proliferation and neuron death (Nd) [9], [10], [11]. Neuronal debris, amyloid-β (Aβ), and/or proliferating astroglia (Ap) may in turn further exacerbate the inflammatory phenotype of M1 macroglia [12], [13]. The multiple positive and negative feedbacks among these cells are thus crucial for neurodegeneration that eventually alters the neuronal structure and function during the pathogenesis of AD (Figure 1).
Figure 1

Schematic of the AD mechanism that incorporates feedback influences from surviving and dead neurons, Ns and Nd, quiescent and proliferating astroglia Aq and Ap, reactive and normal microglia, M1 and M2, and Aβ.

The rates associated with the pathways are included in Table 1.

Schematic of the AD mechanism that incorporates feedback influences from surviving and dead neurons, Ns and Nd, quiescent and proliferating astroglia Aq and Ap, reactive and normal microglia, M1 and M2, and Aβ.

The rates associated with the pathways are included in Table 1.
Table 1

Mathematical parameters describing the functional interactions among various cell types.

Rate1/yearPathwayS(Ns)S(Nd)S(M1)S(M2)Sensitivity
α1 10−5 Aq → Ns 50000−50000−60006000Strong
α2 10−3 Ap → Nd −500500−6060Weak
α3 10−2 M1 → Nd −200200−3535Weak
α4 10−4 M2 → Aq 500−500150−150Weak
α5 10−2 M1 → Ap −331−1Weak
α6 10−2 Ns → M2 500−500−60006000Weak
α7 10−4 Aq → M2 5000−5000−5000050000Strong
α8 10−2 Aβ ⊥ M2 −4004005000−5000Moderate
α9 10−2 M1 ⊥ M2 −3030250−250Weak
α10 10−2 Nd → M1 −8890−90Weak
α11 10−2 Ns ⊥ M1 500−500−60006000Moderate
α12 10−4 Aq ⊥ M1 5000−5000−5000050000Strong
α13 10−2 Aβ → M1 −4004005000−5000Moderate
α14 10−4 M2 ⊥ M1 5000−5000−5000050000Strong
α15 1Ns → Aβ−1010100−100Weak
α16 10−2 M2 ⊥ Aβ100−100−10001000Weak
αr 1M2 ⊥ Aβ8−8−100100Weak

The rates αi associated with the pathways of the AD mechanism, and the sensitivities of the Ns and Nd populations to variations in the values of αi. The values for the sensitivity coefficients S(Nj, j = s, d)  =  dNj/dαi are determined after 20 years for ±2.5% perturbations in each αi value. A cell population is more sensitive to a change in a rate that produces a larger value of |S(Nj)|. Positive S(Nj) imply that a rate contributes to an increase in Nj while a negative value entails a corresponding population decrease.

The rates αi associated with the pathways of the AD mechanism, and the sensitivities of the Ns and Nd populations to variations in the values of αi. The values for the sensitivity coefficients S(Nj, j = s, d)  =  dNj/dαi are determined after 20 years for ±2.5% perturbations in each αi value. A cell population is more sensitive to a change in a rate that produces a larger value of |S(Nj)|. Positive S(Nj) imply that a rate contributes to an increase in Nj while a negative value entails a corresponding population decrease. Due to its multi-cellular components and complex nature, conventional experimental approaches have failed to identify critical underlying causes for AD, contributing to the lack of an effective therapeutic treatment. Mathematical models can serve as powerful tools to understand the molecular and cellular processes that control complex diseases [14], [15]. Indeed, there have been several attempts to model the process of senile plaque formation [16], [17], [18], [19]. Specifically, these approaches focused on a nucleation step that is coupled with rates for the irreversible binding of Aβ monomers to the fibril ends, the lateral aggregation of filaments into fibrils, and fibril elongation through end-to-end association. Other modeling efforts examined the signaling cascade responsible for microglia migration and activation in response to an initial inflammation-provoking stimulus involving Aβ [16], [20]. However, no systematic modeling approaches have been reported to examine the network cross-talks among microglia, neuron, and astroglia, and the corresponding pathological consequence. Here, we evaluate the dynamic network involving multiple cross-talks among distinct states of microglia, astroglia, and neurons through a mathematical model. Our approach has led to an intriguing insight suggesting that microglia activation in addition to a threshold for Aβ may be the critical initiator for the pathogenesis of AD.

Methods

Mathematical Method

We propose a sixteen pathway AD mechanism involving seven species that is shown schematically in Fig. 1. The paths have rates αi that implicitly represent the influences of intercellular signaling along them. The mechanism is based on an assumption of constant risk of neuronal death, i.e., a single event randomly initiates cell death independently of the state of any other neuron at any instant [21]. The spatiotemporal influence of diffusion is neglected since local cell events are assumed to occur on a slower timescale than signal dispersion through chemotaxis. The seven rate equations for the cell populations and the number of Aβ molecules in an arbitrary local volume can be written through seven coupled rate equations, namely, These relate the change in each cell population or the number of Aβ molecules at any instant to the values of all species at that time. For instance, Eq. (1) relates the rate of change in Ns to the Aq, Ap, and M1 populations with the pathway weights α1, α2, and α3, respectively. Whereas Aq increases the rate of change of Ns, Ap and M1 decrease it. Equation (5) for the rate of change of the M2 population is the most complex, since it involves nine pathway weights, and five cell populations and Aβ. The conversion of Ns into Nd is irreversible, whereas those of Aq and M2 into Ap and M1 are reversible. The rates for each αi are specified, as shown in presented in Table 1 for each pathway. Since the literature points to the path NsAβ being dominant, we assume that it is also the fastest. Its rate is set at 1/year, i.e., each year every Ns cell stimulates the formation of a sustaining an Aβ molecule. Likewise, since neuronal survival decreases significantly once disease progresses, we assume that the overall path M2 → AqNs is slow so that the associated rates α1 and α4 are also relatively the smallest. The other rates are similarly specified in terms of their relative abilities to facilitate or inhibit the formation of a cell or Aβ molecule according to the particular pathway. Next, we specify the initial composition of the volume under consideration. These initial conditions for the seven species are presented in Table 2.
Table 2

Sensitivities of the cell types to the initial conditions.

Ns(0)Nd(0)Aq(0)Ap(0)M1(0)M2(0)Aβ (0)
Value 104 102 105 103 103 105 103
S(Ns) 1≈0≈0≈0−0.20≈0
S(Nd) ≈01≈0≈00.2≈0≈0
S(Aq) ≈0≈01≈0−0.2≈0≈0
S(Ap) ≈0≈0≈010.2≈0≈0
S(M1) ≈00.2≈0≈01.2≈0≈0
S(M2) ≈0−0.2≈0≈0−0.21≈0
S(Aβ) 1≈0≈0≈0−0.2≈0≈0

Initial values X(0) of the initial cell populations and the number of molecules of Aβ in an arbitrary local volume and orders of magnitude for the sensitivity coefficients S(Nj, j = s,d)  =  dNj/d(X(0)) determined after 20 years for tenfold perturbations, i.e., 10× and 10−1×, in these initial values.

Initial values X(0) of the initial cell populations and the number of molecules of Aβ in an arbitrary local volume and orders of magnitude for the sensitivity coefficients S(Nj, j = s,d)  =  dNj/d(X(0)) determined after 20 years for tenfold perturbations, i.e., 10× and 10−1×, in these initial values.

Results

Our objective is to be able to describe neuropathogenesis during AD in terms of the Ns and Nd populations. Hence, we first determine the sensitivities of these cells to changes in the rates αi, using the usual definition of the sensitivity coefficient, The sensitivity coefficients for Ns, Nd, M1 and M2 cells, presented in Table 1, are determined after 20 years for ±2.5% perturbations in each αi value. A cell population is more sensitive to a change in a rate that produces a larger value of |S(Nj)|. Positive values for S(Nj) imply that a rate contributes to an increase in Nj while a negative value implies that its influence leads to a corresponding population decrease. The sensitivity analysis shows that the Ns and Nd populations are most sensitive to the path AqNs, which increases neuronal survival and decreases neuron death. Important paths that inhibit neuropathogenesis include Aq → M2, Aq ⊥ M1 and M2 ⊥ M1, while those that enhance disease involve M1 → Nd, Aβ ⊥ M2 and Aβ → M1. A similar analysis that perturbs the initial cell populations and the number of Aβ molecules tenfold is presented in Table 2. It shows that, in comparison to the other species, the M1 population is most sensitive to these substantial perturbations in the initial amount of any species while Nd is only sensitive to the initial amounts of M1 and M2. This implies an important role for microglia during AD progression. The sensitivity coefficients S(M1) and S(M2), also presented in Table 1, show that, as for Ns and Nd, the dominant paths that inhibit neuropathogenesis by affirming M2 and decreasing M1 are also Aq → M2, Aq ⊥ M1 and M2 ⊥ M1. Once again, paths 7 and 14 involving Aβ, i.e., Aβ ⊥ M2 and Aβ → M1 promote AD progression. The model suggests that interventions aimed at decreasing α8 and α13, which involve M1, M2 and Aβ and contribute to AD progression, are the ones more likely to diminish neuropathogenesis. This intuitive result emphasizes that decreasing the number of reactive microglia and ensuring a sufficient population of quiescent astroglia is important in treating AD. The temporal variation in various species for the rates in Table 1 is illustrated in Fig. 2. Figure 2(a) presents the Ns, M1 and Aβ populations over 20 years, and Fig. 2(b) the corresponding values for Nd and Ap. Most notable is the influence of the removal rate αr, which stabilizes the number of Aβ molecules after three years. Following that period, there is only a gradual increase in Nd that is coupled with a corresponding decline in Ns. Consequently, the microglia populations are also relatively stable. Therefore, the rates in Table 1 should be considered as being representative of a healthy population.
Figure 2

Dynamic simulation of various cell populations during the progression of Alzheimer's disease.

The (a) Ns (black), M1 (red) and Aβ (blue), and (b) Nd (black) and Ap (blue) populations over 20 years for the rates reported in Table 1. The removal rate αr stabilizes the net number of Aβ molecules after three years so that there is only a gradual increase in Nd and corresponding decline in Ns thereafter. The microglia populations are also consequently relatively stable.

Dynamic simulation of various cell populations during the progression of Alzheimer's disease.

The (a) Ns (black), M1 (red) and Aβ (blue), and (b) Nd (black) and Ap (blue) populations over 20 years for the rates reported in Table 1. The removal rate αr stabilizes the net number of Aβ molecules after three years so that there is only a gradual increase in Nd and corresponding decline in Ns thereafter. The microglia populations are also consequently relatively stable. We examine the influence of varying αr on neuropathogeneis in Fig. 3, which presents the M1, Ap, Aβ and Nd populations over 20 years for three values of αr. As αr decreases, there is an increasing neuronal death. Thus, all four populations, which are associated with AD progression, increase. While microglia play an important role in AD, Fig. 3 shows how the local Aβ concentration plays a critical role in initiating and promoting AD.
Figure 3

Dynamic variations of cell populations given distinct Aβ removal rate.

Variations in the (a) M1, (b) Ap, (c) Aβ, and (d) Nd populations over 20 years for three values of αr  =  1× (black), 10−1× (red), and 10−2× (blue) the value reported in Table 1 for the Aβ removal rate. As αr decreases, there is an increase in neuropathogenesis so that all four populations increase.

Dynamic variations of cell populations given distinct Aβ removal rate.

Variations in the (a) M1, (b) Ap, (c) Aβ, and (d) Nd populations over 20 years for three values of αr  =  1× (black), 10−1× (red), and 10−2× (blue) the value reported in Table 1 for the Aβ removal rate. As αr decreases, there is an increase in neuropathogenesis so that all four populations increase. We investigate this further by varying α8 and α13. Figure 4 presents results for the M1, Nd and Aβ populations over 20 years for three values of α13. As α13 increases, the M1, Ap and Nd populations also increase, leading to an associated decrease in neuronal survival, as illustrated through Eqs. (1) and (2) of the mathematical model. A tenfold increase in α13 leads to a near doubling in Nd after 20 years. As Ns decreases so does Aβ, but the smaller protein concentration is still sufficient to promote neuropathogenesis among the smaller Ns population. Identical results are obtained for similar variations in the rate α8 for Aβ ⊥ M2, since the sensitivity coefficients for each of M1 and Nd towards paths 8 and 13 are identical.
Figure 4

Dynamic variations of cell populations given distinct impacts of Aβ on M1 macrophages (the value of α13).

Variations in the (a) M1, (b) Nd and (c) Aβ populations over 20 years for three values of α13  =  1× (black), 10× (red), and 50× (blue) the value reported in Table 1 for the path Aβ → M1. As α13 increases, M1 and Nd also increase and, consequently, there is an associated decrease in neuronal survival. This is also illustrated through Eqs. (1) and (2) of the mathematical model.

Dynamic variations of cell populations given distinct impacts of Aβ on M1 macrophages (the value of α13).

Variations in the (a) M1, (b) Nd and (c) Aβ populations over 20 years for three values of α13  =  1× (black), 10× (red), and 50× (blue) the value reported in Table 1 for the path Aβ → M1. As α13 increases, M1 and Nd also increase and, consequently, there is an associated decrease in neuronal survival. This is also illustrated through Eqs. (1) and (2) of the mathematical model.

Discussion

We present a mathematical model for neuropathogenesis during AD that involves neurons, normal and reactive glial cells, and Aβ. It uses neuronal death as a surrogate for senile plaque formation. By monitoring neuronal health, we are able to identify intuitive strategies for interventions. In particular, the model suggests that the most effective intervention is one that improves the inhibition of reactive microglia and Aβ by normal microglia, and ensuring a sufficient population of quiescent astroglia. Overall, neuropathogenesis proceeds through the production of reactive microglia. Our analysis is consistent with experimental data that indicate that inflammation may be an early initiator for AD, long before the apparent senile plaque formation [22], [23]. It further reinforces the notion that additional studies should be directed at examining earlier inflammatory signals and alterations involving microglia as a key node so as to better define AD initiation and understand mechanisms for effective prevention and treatment of the disease. We realize that our mathematical analysis is an initial attempt to examine AD and may not fully account for the associate intertwined cellular communication pathways. Nevertheless, it serves as a hypothesis provoking and building process that should encourage integrated analyses of AD pathogenesis. Future experimental data examining the cross-talks among microglia, astroglia, and neurons will allow us to better refine our model and implement realistic parameters in the rate equations.
  22 in total

1.  Kinetic theory of fibrillogenesis of amyloid beta-protein.

Authors:  A Lomakin; D B Teplow; D A Kirschner; G B Benedek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Alzheimer's disease: genotypes, phenotypes, and treatments.

Authors:  D J Selkoe
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

3.  A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state.

Authors:  M M Pallitto; R M Murphy
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

4.  Mathematical model for the cancer stem cell hypothesis.

Authors:  R Ganguly; I K Puri
Journal:  Cell Prolif       Date:  2006-02       Impact factor: 6.831

5.  A one-hit model of cell death in inherited neuronal degenerations.

Authors:  G Clarke; R A Collins; B R Leavitt; D F Andrews; M R Hayden; C J Lumsden; R R McInnes
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

Review 6.  Inflammation, microglia, and Alzheimer's disease.

Authors:  Brent Cameron; Gary E Landreth
Journal:  Neurobiol Dis       Date:  2009-10-13       Impact factor: 5.996

7.  Chemotactic signaling, microglia, and Alzheimer's disease senile plaques: is there a connection?

Authors:  Magdalena Luca; Alexandra Chavez-Ross; Leah Edelstein-Keshet; Alex Mogilner
Journal:  Bull Math Biol       Date:  2003-07       Impact factor: 1.758

8.  Exploring the formation of Alzheimer's disease senile plaques in silico.

Authors:  Leah Edelstein-keshet; Athan Spiros
Journal:  J Theor Biol       Date:  2002-06-07       Impact factor: 2.691

9.  Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.

Authors:  Sherri Dudal; Pascale Krzywkowski; Julie Paquette; Céline Morissette; Diane Lacombe; Patrick Tremblay; Francine Gervais
Journal:  Neurobiol Aging       Date:  2004-08       Impact factor: 4.673

10.  Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development.

Authors:  Y Pang; L Campbell; B Zheng; L Fan; Z Cai; P Rhodes
Journal:  Neuroscience       Date:  2009-12-24       Impact factor: 3.590

View more
  18 in total

1.  Examining the Role of Microglia and Astroglia During the Pathogenesis of Alzheimer's Disease via the Puri-Li Model.

Authors:  R A Thuraisingham
Journal:  J Mol Neurosci       Date:  2017-07-13       Impact factor: 3.444

2.  Pathogenesis of Alzheimer's Disease Examined Using a Modified Puri-Li Model that Incorporates Calcium Ion Homeostasis.

Authors:  R A Thuraisingham
Journal:  J Mol Neurosci       Date:  2018-05-13       Impact factor: 3.444

3.  Computational modeling of cytokine signaling in microglia.

Authors:  Warren D Anderson; Hirenkumar K Makadia; Andrew D Greenhalgh; James S Schwaber; Samuel David; Rajanikanth Vadigepalli
Journal:  Mol Biosyst       Date:  2015-12

4.  A Model for Improving the Learning Curves of Artificial Neural Networks.

Authors:  Roberto L S Monteiro; Tereza Kelly G Carneiro; José Roberto A Fontoura; Valéria L da Silva; Marcelo A Moret; Hernane Borges de Barros Pereira
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

5.  Mathematical model on Alzheimer's disease.

Authors:  Wenrui Hao; Avner Friedman
Journal:  BMC Syst Biol       Date:  2016-11-18

Review 6.  Modelling the molecular mechanisms of aging.

Authors:  Mark T Mc Auley; Alvaro Martinez Guimera; David Hodgson; Neil Mcdonald; Kathleen M Mooney; Amy E Morgan; Carole J Proctor
Journal:  Biosci Rep       Date:  2017-02-23       Impact factor: 3.840

Review 7.  The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future Directions.

Authors:  A Lloret-Villas; T M Varusai; N Juty; C Laibe; N Le NovÈre; H Hermjakob; V Chelliah
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-01-07

8.  Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis.

Authors:  Christina Rose Kyrtsos; John S Baras
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

9.  Altered intrinsic excitability of hippocampal CA1 pyramidal neurons in aged PDAPP mice.

Authors:  Francesco Tamagnini; Janet Novelia; Talitha L Kerrigan; Jon T Brown; Krasimira Tsaneva-Atanasova; Andrew D Randall
Journal:  Front Cell Neurosci       Date:  2015-10-14       Impact factor: 5.505

10.  The development of a stochastic mathematical model of Alzheimer's disease to help improve the design of clinical trials of potential treatments.

Authors:  Christoforos Hadjichrysanthou; Alison K Ower; Frank de Wolf; Roy M Anderson
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.